Mass. diagnostics firms sign M & A deals worth $500M
Two local diagnostics firms, one of which is working in the increasingly competitive field of cancer testing, closed acquisition deals this week worth around $500 million.
Billerica-based Quanterix Corp. (Nasdaq: QTRX) announced this week it will buy Swedish firm UmanDiagnostics AB for $22.5 million.
By purchasing Uman, Quanterix will get access to a cache of antibodies that can detect an element called neurofilament light. Quanterix’s commercial diagnostic t ool looks for small amounts of…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Allison DeAngelis Source Type: news
More News: Biotechnology | Brain | Cancer | Cancer & Oncology | Health Management | Mergers and Aquisitions | Neurology | Sweden Health